These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 25159681)

  • 1. Personalizing risk stratification by addition of PAK1 expression to TNM staging: improving the accuracy of clinical decision for gastroesophageal junction adenocarcinoma.
    Li Z; Zou X; Xie L; Chen H; Chen Y; Yeung SC; Zhang H
    Int J Cancer; 2015 Apr; 136(7):1636-45. PubMed ID: 25159681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic importance and therapeutic implications of PAK1, a drugable protein kinase, in gastroesophageal junction adenocarcinoma.
    Li Z; Zou X; Xie L; Dong H; Chen Y; Liu Q; Wu X; Zhou D; Tan D; Zhang H
    PLoS One; 2013; 8(11):e80665. PubMed ID: 24236193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prognostic value of metastatic lymph node ratio in adenocarcinoma of the gastroesophageal junction].
    Zhang HD; Ma Z; Tang P; Duan XF; Ren P; Yue J; Yu ZT
    Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Sep; 16(9):822-6. PubMed ID: 24061985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of number of metastatic lymph nodes and metastatic lymph node ratio on the prognosis in patients with adenocarcinoma of the esophagogastric junction after curative resection].
    Zhang H; Chen C; Yue J; Ma M; Ma Z; Yu Z
    Zhonghua Zhong Liu Za Zhi; 2014 Feb; 36(2):141-6. PubMed ID: 24796465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extranodal metastasis is a powerful prognostic factor in patients with adenocarcinoma of the esophagogastric junction.
    Zhang HD; Tang P; Duan XF; Chen CG; Ma Z; Gao YY; Zhang H; Yu ZT
    J Surg Oncol; 2013 Dec; 108(8):542-9. PubMed ID: 24018956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymph node metastases of adenocarcinoma of the esophagus and esophagogastric junction.
    Zhang X; Watson DI; Jamieson GG
    Chin Med J (Engl); 2007 Dec; 120(24):2268-70. PubMed ID: 18167216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of Circulating Tumor DNA and Clinical Correlates in Patients with Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma.
    Kato S; Okamura R; Baumgartner JM; Patel H; Leichman L; Kelly K; Sicklick JK; Fanta PT; Lippman SM; Kurzrock R
    Clin Cancer Res; 2018 Dec; 24(24):6248-6256. PubMed ID: 30348637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can extracapsular lymph node involvement be a tool to fine-tune pN1 for adenocarcinoma of the oesophagus and gastro-oesophageal junction in the Union Internationale contre le Cancer (UICC) TNM 7th edition?†.
    Nafteux P; Lerut T; De Hertogh G; Moons J; Coosemans W; Decker G; Van Veer H; De Leyn P
    Eur J Cardiothorac Surg; 2014 Jun; 45(6):1001-10. PubMed ID: 24477743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphangiogenesis and prognostic significance of vascular endothelial growth factor C in gastro-oesophageal junction adenocarcinoma.
    Xie LX; Zhai TT; Yang LP; Yang E; Zhang XH; Chen JY; Zhang H
    Int J Exp Pathol; 2013 Feb; 94(1):39-46. PubMed ID: 23317352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nodal staging in adenocarcinoma of the gastro-esophageal junction. Proposal of a specific staging system.
    Pedrazzani C; deManzoni G; Marrelli D; Giacopuzzi S; Corso G; Bernini M; Roviello F
    Ann Surg Oncol; 2007 Feb; 14(2):299-305. PubMed ID: 17146743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Staging of adenocarcinoma of the gastroesophageal junction.
    Parry K; Haverkamp L; Bruijnen RC; Siersema PD; Offerhaus GJ; Ruurda JP; van Hillegersberg R
    Eur J Surg Oncol; 2016 Mar; 42(3):400-6. PubMed ID: 26777127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymph node involvement in advanced gastroesophageal junction adenocarcinoma.
    Pedrazzani C; de Manzoni G; Marrelli D; Giacopuzzi S; Corso G; Minicozzi AM; Rampone B; Roviello F
    J Thorac Cardiovasc Surg; 2007 Aug; 134(2):378-85. PubMed ID: 17662776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of number and site of lymph node invasion on survival of adenocarcinoma of esophagogastric junction.
    Ielpo B; Pernaute AS; Elia S; Buonomo OC; Valladares LD; Aguirre EP; Petrella G; Garcia AT
    Interact Cardiovasc Thorac Surg; 2010 May; 10(5):704-8. PubMed ID: 20154347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carbohydrate antigen 19-9 is a useful prognostic marker in esophagogastric junction adenocarcinoma.
    Tokunaga R; Imamura Y; Nakamura K; Uchihara T; Ishimoto T; Nakagawa S; Iwatsuki M; Baba Y; Sakamoto Y; Miyamoto Y; Yoshida N; Oyama S; Shono T; Naoe H; Saeki H; Oki E; Watanabe M; Sasaki Y; Maehara Y; Baba H
    Cancer Med; 2015 Nov; 4(11):1659-66. PubMed ID: 26310928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathological features and prognostic factors of adenocarcinoma of the esophagogastric junction according to Siewert classification: experiences at a single institution in Japan.
    Hosokawa Y; Kinoshita T; Konishi M; Takahashi S; Gotohda N; Kato Y; Daiko H; Nishimura M; Katsumata K; Sugiyama Y; Kinoshita T
    Ann Surg Oncol; 2012 Feb; 19(2):677-83. PubMed ID: 21822549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of old and new TNM systems for nodal staging in adenocarcinoma of the gastro-oesophageal junction.
    de Manzoni G; Pedrazzani C; Verlato G; Roviello F; Pasini F; Pugliese R; Cordiano C
    Br J Surg; 2004 Mar; 91(3):296-303. PubMed ID: 14991629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Explored Risk Factors for Lymph Node Metastasis with Siewert II/III Adenocarcinoma of the Gastroesophageal Junction.
    Zheng Z; Yin J; Wu HW; Li J; Cai J; Qin SQ; Zhang J; Yao HW; Li JS; Zhang ZT
    Anticancer Res; 2017 Aug; 37(8):4605-4610. PubMed ID: 28739759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Siewert III esophagogastric junction adenocarcinoma: does TNM 8th save us?
    Zanoni A; Verlato G; Baiocchi GL; Casella F; Cossu A; d'Ignazio A; De Pascale S; Giacopuzzi S
    Updates Surg; 2018 Jun; 70(2):241-249. PubMed ID: 29808375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nomogram predicted survival of patients with adenocarcinoma of esophagogastric junction.
    Zhou Z; Zhang H; Xu Z; Li W; Dang C; Song Y
    World J Surg Oncol; 2015 Jun; 13():197. PubMed ID: 26055624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival in Patients With Esophageal Adenocarcinoma Undergoing Trimodality Therapy Is Independent of Regional Lymph Node Location.
    Sepesi B; Schmidt HE; Lada M; Correa AM; Walsh GL; Mehran RJ; Rice DC; Roth JA; Vaporciyan AA; Ajani JA; Watson TJ; Swisher SG; Low DE; Hofstetter WL
    Ann Thorac Surg; 2016 Mar; 101(3):1075-80; Discussion 1080-1. PubMed ID: 26680311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.